SCRIBE THERAPEUTICS - Q2 2026 NET LOSS $6.50 MLN OR $2.62 PER SHARE VS $9.90 MLN OR $4.08 PER SHARE IN Q2 2025

Reuters · 3d ago

Please log in to view news